Skip to main content

Advertisement

Fig. 6 | Breast Cancer Research

Fig. 6

From: Prexasertib treatment induces homologous recombination deficiency and synergizes with olaparib in triple-negative breast cancer cells

Fig. 6

a, b Colony assay plates of MDAMB231 cells with various concentration of prexasertib and/or olaparib. c Survival fraction of MDAMB231 cells treated with various concentrations of prexasertib and/or olaparib. d Combination index values of MDAMB231 cells treated with various concentrations of prexasertib and/or olaparib. e Survival fraction of MDAMB453 cells treated with various concentrations of prexasertib and/or olaparib. f Combination index values of MDAMB453 cells treated with various concentrations of prexasertib and/or olaparib

Back to article page